Top ten research priorities for type 2 diabetes: results from the Diabetes UK-James Lind Alliance Priority Setting Partnership

Twenty per cent of the UK population are living with, or are at risk of, type 2 diabetes (T2D), with estimated annual NHS treatment costs of £8.8 billion. This rising tide identifies an urgent need to reduce uncertainties around the causes, prevention, and treatment of T2D. A patient-centred appro...

Full description

Bibliographic Details
Main Authors: Finer, S, Robb, P, Cowan, K, Daly, A, Robertson, E, Farmer, A
Format: Journal article
Language:English
Published: Elsevier 2017
_version_ 1797056024579932160
author Finer, S
Robb, P
Cowan, K
Daly, A
Robertson, E
Farmer, A
author_facet Finer, S
Robb, P
Cowan, K
Daly, A
Robertson, E
Farmer, A
author_sort Finer, S
collection OXFORD
description Twenty per cent of the UK population are living with, or are at risk of, type 2 diabetes (T2D), with estimated annual NHS treatment costs of £8.8 billion. This rising tide identifies an urgent need to reduce uncertainties around the causes, prevention, and treatment of T2D. A patient-centred approach is a cornerstone of high quality diabetes care and is mirrored in research by an increasing focus on patient and public involvement. The James Lind Alliance (JLA) has a 13-year history of collaboration with patients, carers and clinicians identifying and prioritising unmet research needs to drive improvements in clinical care. A Priority Setting Partnership (PSP) was set up in 2015 by Diabetes UK and the JLA to identify key priorities for future T2D research.
first_indexed 2024-03-06T19:17:30Z
format Journal article
id oxford-uuid:18e868ed-2dfc-412e-935c-64f9b3cbfa68
institution University of Oxford
language English
last_indexed 2024-03-06T19:17:30Z
publishDate 2017
publisher Elsevier
record_format dspace
spelling oxford-uuid:18e868ed-2dfc-412e-935c-64f9b3cbfa682022-03-26T10:45:53ZTop ten research priorities for type 2 diabetes: results from the Diabetes UK-James Lind Alliance Priority Setting PartnershipJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:18e868ed-2dfc-412e-935c-64f9b3cbfa68EnglishSymplectic Elements at OxfordElsevier2017Finer, SRobb, PCowan, KDaly, ARobertson, EFarmer, ATwenty per cent of the UK population are living with, or are at risk of, type 2 diabetes (T2D), with estimated annual NHS treatment costs of £8.8 billion. This rising tide identifies an urgent need to reduce uncertainties around the causes, prevention, and treatment of T2D. A patient-centred approach is a cornerstone of high quality diabetes care and is mirrored in research by an increasing focus on patient and public involvement. The James Lind Alliance (JLA) has a 13-year history of collaboration with patients, carers and clinicians identifying and prioritising unmet research needs to drive improvements in clinical care. A Priority Setting Partnership (PSP) was set up in 2015 by Diabetes UK and the JLA to identify key priorities for future T2D research.
spellingShingle Finer, S
Robb, P
Cowan, K
Daly, A
Robertson, E
Farmer, A
Top ten research priorities for type 2 diabetes: results from the Diabetes UK-James Lind Alliance Priority Setting Partnership
title Top ten research priorities for type 2 diabetes: results from the Diabetes UK-James Lind Alliance Priority Setting Partnership
title_full Top ten research priorities for type 2 diabetes: results from the Diabetes UK-James Lind Alliance Priority Setting Partnership
title_fullStr Top ten research priorities for type 2 diabetes: results from the Diabetes UK-James Lind Alliance Priority Setting Partnership
title_full_unstemmed Top ten research priorities for type 2 diabetes: results from the Diabetes UK-James Lind Alliance Priority Setting Partnership
title_short Top ten research priorities for type 2 diabetes: results from the Diabetes UK-James Lind Alliance Priority Setting Partnership
title_sort top ten research priorities for type 2 diabetes results from the diabetes uk james lind alliance priority setting partnership
work_keys_str_mv AT finers toptenresearchprioritiesfortype2diabetesresultsfromthediabetesukjameslindallianceprioritysettingpartnership
AT robbp toptenresearchprioritiesfortype2diabetesresultsfromthediabetesukjameslindallianceprioritysettingpartnership
AT cowank toptenresearchprioritiesfortype2diabetesresultsfromthediabetesukjameslindallianceprioritysettingpartnership
AT dalya toptenresearchprioritiesfortype2diabetesresultsfromthediabetesukjameslindallianceprioritysettingpartnership
AT robertsone toptenresearchprioritiesfortype2diabetesresultsfromthediabetesukjameslindallianceprioritysettingpartnership
AT farmera toptenresearchprioritiesfortype2diabetesresultsfromthediabetesukjameslindallianceprioritysettingpartnership